Jessica Tierney

Partner

Washington + 1.202.879.3474

Jessica Tierney has more than 15 years of experience with U.S. Food & Drug Administration (FDA) regulation, enforcement, and related litigation. A former FDA attorney, she draws on her insider's view of the agency to counsel and defend clients across every FDA-regulated product sector, including food, dietary supplements, tobacco, drugs, medical devices, and veterinary products.

Jessica advises companies bringing novel products to market, from pre-market strategy and submissions through labeling, advertising, and launch.

Clients turn to Jessica when the stakes with FDA are highest. She guides companies through recalls and market withdrawals, responses to FDA 483 inspectional observations and warning letters, import detentions, and other enforcement actions. She also advises on current good manufacturing practice (cGMP) and marketing compliance. When disputes escalate, Jessica represents clients in litigation and contested claims involving FDA-regulated products. This includes challenges to agency action, product liability and consumer class actions over labeling and marketing claims, false advertising disputes, and government investigations.

Before joining Jones Day in 2022, Jessica practiced at a Washington, D.C. law firm. Earlier, she held senior positions in FDA's Center for Tobacco Products and Center for Drug Evaluation and Research. There she developed regulations and guidance, drafted agency responses to citizen petitions, advised key stakeholders on the Federal Food, Drug, and Cosmetic Act (FD&C Act), and consulted on labeling disputes. That experience gives her a practical understanding of how the agency builds its regulatory and enforcement positions. She uses it to develop solutions for complex regulatory matters and to help clients engage with public health policy.

Experience

  • Riverside portfolio company acquires CSB NutritionJones Day advised The Riverside Company in the acquisition by portfolio company Western Botanicals of CSB Nutrition (CSB), a contract developer and manufacturer (CDMO) of vitamin, mineral, herbal and dietary supplements.
  • Riverside acquires Yellow EmperorJones Day advised The Riverside Company in the acquisition and financing of Yellow Emperor, a leading liquid dietary supplement developer and manufacturer, as the first add-on investment for portfolio company Western Botanicals (WB Blends).
  • EagleTree Capital sells gChem to ContextLogic HoldingsJones Day is advising EagleTree Capital in the $850 million sale of Gaylord Chemical Company, L.L.C. (gChem) to ContextLogic Holdings Inc.
  • Riverside sells YumEarth to ACONJones Day advised The Riverside Company in the sale of YumEarth, a leading clean, organic, allergen-free candy company, to ACON Investments.
  • Verily spins out from Alphabet and raises $300 millionJones Day represented Verily Health in its spin-out from Alphabet, Inc., corporate restructuring and $300 million new money financing.
  • TreeHouse Foods goes private in $2.9 billion sale to InvestindustrialJones Day represented TreeHouse Foods, Inc. (NYSE: THS) in a $2.9 billion take-private transaction whereby an affiliate of Investindustrial, a leading European group of independently managed investment, holding, and advisory companies, acquired TreeHouse Foods in an all-cash transaction.
  • West Pharmaceutical Services sells manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System to AbbVieJones Day is advising West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, in the sale of all manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System and associated facilities to AbbVie (NYSE: ABBV) for $112.5 million at close, subject to working capital and other adjustments.
  • Koch subsidiary acquires Anchor PackagingJones Day advised Koch, Inc. in the acquisition by subsidiary, Georgia Pacific, of Anchor Packaging, a leading manufacturer of rigid food containers and cling film for the food service, retail and processor channels, from TJC (formerly known as The Jordan Company), a New York City-based private equity firm.
  • Tenant obtains dismissal of eviction action and waiver of all alleged past-due rent; landlord required to make repairsJones Day represented a tenant who lives with her teenage children and newborn in an apartment that is infested by cockroaches and rodents and contaminated by mold, among other issues.
  • Radial Equity acquires Premier Dental Products CompanyJones Day advised Radial Equity Partners in the acquisition and financing of Premier Dental Products Company, a leading developer and manufacturer of consumable dental products.
  • Direct lender provides $191 million senior secured credit facility to large private equity-backed leading national provider of pharmaceutical suppliesJones Day advised a direct lender, as administrative agent, in connection with a $191 million senior secured credit facility, which consisted of a $20 million revolver and a $171 million term loan, provided to a large private equity sponsored company that is a leading national provider of pharmaceutical supplies.